1. Home
  2. FDUS vs VALN Comparison

FDUS vs VALN Comparison

Compare FDUS & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDUS
  • VALN
  • Stock Information
  • Founded
  • FDUS 2011
  • VALN 2012
  • Country
  • FDUS United States
  • VALN France
  • Employees
  • FDUS N/A
  • VALN N/A
  • Industry
  • FDUS Finance/Investors Services
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FDUS Finance
  • VALN Health Care
  • Exchange
  • FDUS Nasdaq
  • VALN Nasdaq
  • Market Cap
  • FDUS 654.0M
  • VALN 542.5M
  • IPO Year
  • FDUS 2011
  • VALN 2021
  • Fundamental
  • Price
  • FDUS $19.93
  • VALN $5.62
  • Analyst Decision
  • FDUS Hold
  • VALN Strong Buy
  • Analyst Count
  • FDUS 1
  • VALN 3
  • Target Price
  • FDUS $20.00
  • VALN $15.33
  • AVG Volume (30 Days)
  • FDUS 183.5K
  • VALN 81.8K
  • Earning Date
  • FDUS 07-31-2025
  • VALN 08-12-2025
  • Dividend Yield
  • FDUS 11.34%
  • VALN N/A
  • EPS Growth
  • FDUS N/A
  • VALN N/A
  • EPS
  • FDUS 2.33
  • VALN N/A
  • Revenue
  • FDUS $147,999,000.00
  • VALN $201,099,222.00
  • Revenue This Year
  • FDUS $4.94
  • VALN $18.74
  • Revenue Next Year
  • FDUS $6.51
  • VALN $29.26
  • P/E Ratio
  • FDUS $8.56
  • VALN N/A
  • Revenue Growth
  • FDUS 9.06
  • VALN 21.64
  • 52 Week Low
  • FDUS $16.70
  • VALN $3.62
  • 52 Week High
  • FDUS $23.55
  • VALN $8.66
  • Technical
  • Relative Strength Index (RSI)
  • FDUS 48.50
  • VALN 31.31
  • Support Level
  • FDUS $19.40
  • VALN $5.70
  • Resistance Level
  • FDUS $19.95
  • VALN $6.40
  • Average True Range (ATR)
  • FDUS 0.28
  • VALN 0.20
  • MACD
  • FDUS -0.08
  • VALN -0.05
  • Stochastic Oscillator
  • FDUS 41.41
  • VALN 0.00

About FDUS Fidus Investment Corporation

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: